Oncology & Cancer

UK cancer treatment falls behind other countries, research finds

People in the UK have been treated with chemotherapy and radiotherapy less often than patients in comparable countries, and faced long waits for treatments, according to two new studies published in The Lancet Oncology.

Medications

Review paper compares two leading pancreatic cancer drugs

An in-depth analysis of two common treatments for advanced pancreatic cancer from The University of Toledo has found the combination chemotherapy drug Folfirinox is more likely to promote progression-free survival—a notable ...

page 3 from 40